AMG 334 CGRP antibody for migraine: time to celebrate?
- PMID: 26879278
- DOI: 10.1016/S1474-4422(16)00040-5
AMG 334 CGRP antibody for migraine: time to celebrate?
Comment on
-
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.Lancet Neurol. 2016 Apr;15(4):382-90. doi: 10.1016/S1474-4422(16)00019-3. Epub 2016 Feb 12. Lancet Neurol. 2016. PMID: 26879279 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
